STAT3 and metabolic dysfunction-associated steatotic liver disease: Leptin was recently found to induce CD14 expression via activation of signal transducer and activator of transcription 3 (STAT3) signaling in KCs, resulting in enhanced responsivity against low-dose LPS in the liver (Imajo et al., 2012), which contributes to the progression of NAFLD.